Valuation: BioGaia AB

Market Cap 11.96B 1.22B 1.08B 1B 920M 1.72B 119B 1.76B 4.66B 57.81B 4.59B 4.5B 201B P/E 2026 *
30.9x
P/E 2027 * 25.2x
Enterprise Value 11.29B 1.16B 1.02B 944M 868M 1.63B 112B 1.66B 4.4B 54.58B 4.34B 4.24B 189B EV / Sales 2026 *
6.76x
EV / Sales 2027 * 6.03x
Free-Float
80.82%
Yield 2026 *
2.5%
Yield 2027 * 2.71%
1 day+0.77%
1 week+1.90%
Current month+1.11%
1 month+0.94%
3 months-1.09%
6 months+4.69%
Current year+11.30%
1 week 116.3
Extreme 116.3
124.9
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 46.7
Extreme 46.7
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Director

582 0.0006%
12/30/25 A Buy

General Counsel

390 0.0004%
12/5/25 A Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
+0.77%+1.90%+18.91%+16.22% 1.22B
+0.11%-3.98%+13.89%-11.26% 66.32B
-0.12%+2.23%+36.63%+196.27% 52.6B
+0.51%+37.90%+37.90%+37.90% 43.27B
-1.32%-7.38%-57.63%-57.10% 38.64B
+1.46%-3.97%+53.17%-27.51% 29.62B
+0.78%+0.03%+65.07%+81.90% 23.31B
-1.81%-9.71%+64.46%-54.90% 22.62B
-1.87%+0.45%+1.30%+169.13% 20.22B
-1.04%-1.59%+66.57%+119.96% 16.29B
Average -0.25%-2.42%+30.03%+47.06% 31.41B
Weighted average by Cap. -0.20%-2.58%+25.29%+45.38%

Financials

2026 *2027 *
Net sales 1.67B 171M 150M 140M 128M 241M 16.55B 245M 651M 8.07B 642M 628M 28B 1.88B 192M 169M 157M 144M 271M 18.6B 276M 732M 9.07B 721M 705M 31.47B
Net income 387M 39.61M 34.84M 32.36M 29.77M 55.82M 3.84B 56.82M 151M 1.87B 149M 145M 6.49B 474M 48.51M 42.67M 39.64M 36.46M 68.37M 4.7B 69.59M 185M 2.29B 182M 178M 7.95B
Net Debt -667M -68.27M -60.04M -55.78M -51.3M -96.21M -6.61B -97.93M -260M -3.22B -256M -251M -11.19B -646M -66.07M -58.11M -53.98M -49.65M -93.11M -6.4B -94.77M -252M -3.12B -248M -243M -10.83B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
23/07/26 SEK 118.20 +0.77% 92,151
22/07/26 SEK 117.30 -2.57% 119,418
21/07/26 SEK 120.40 +1.18% 265,484
20/07/26 SEK 119.00 -4.65% 276,178
17/07/26 SEK 124.80 +7.59% 598,880
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
118.20SEK
Average target price
152.50SEK
Spread / Average Target
+29.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock